Jerry Colca
Company: Cirius Therapeutics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Deliberating the Next Steps Towards the Identification & Application of Non-Invasive Biomarkers for NASH 2:00 pm
Discussing appropriate biomarkers for patients’ segmentation and better understanding heterogeneity Maximizing treatment responsiveness by leveraging predictive biomarkers (responder vs non-responder) Efforts on linking NITs to clinical outcome/benefitsRead more
day: Seminar B PM tracks
New Metabolic Target & Metabolic Marker Suggest a Way Forward in Metabolic Associated Steatotic Liver Disease (MASLD) 1:00 pm
New view of the pathophysiology of MASLD/MASH: further examing Phase 2b data for an insulin sensitizer with a newly appreciated mitochondrial target Fasting hyperinsulinemia as an addressable marker for reduced liver function leading to disease progression Exploring metabolic reprogramming in multiple cell types to address multi-organ involvement in the pathologyRead more
day: Seminar B PM tracks